Thyroid hormone has profound effects on metabolic homeostasis, regulating both lipogenesis and lipolysis, primarily by modulating adrenergic activity. We generated mice with a point mutation in the thyroid hormone receptor ␣ (TR␣) gene producing a dominant-negative TR␣ mutant receptor with a proline to histidine substitution (P398H). The heterozygous P398H mutant mice had a 3.4-fold (p < 0.02) increase in serum thyrotropin (TSH) levels. Serum triiodothyronine (T3) and thyroxine (T4) concentrations were slightly elevated compared with wild-type mice. The P398H mice had a 4.4-fold increase in body fat (as a fraction of total body weight) (p < 0.001) and a 5-fold increase in serum leptin levels (p < 0.005) compared with wild-type mice. A 3-fold increase in serum fasting insulin levels (p < 0.002) and a 55% increase in fasting glucose levels (p < 0.01) were observed in P398H compared with wild-type mice. There was a marked reduction in norepinephrine-induced lipolysis, as reflected in reduced glycerol release from white adipose tissue isolated from P398H mice. Heart rate and cold-induced adaptive thermogenesis, mediated by thyroid hormone-catecholamine interaction, were also reduced in P398H mice. In conclusion, the TR␣ P398H mutation is associated with visceral adiposity and insulin resistance primarily due to a marked reduction in catecholamine-stimulated lipolysis. The observed phenotype in the TR␣ P398H mouse is likely due to interference with TR␣ action as well as influence on other metabolic signaling pathways. The physiologic significance of these findings will ultimately depend on understanding the full range of actions of this mutation.Thyroid hormone plays a central role in metabolic homeostasis. Thyroid hormone stimulates basal metabolic rate and adaptive thermogenesis. Hyperthyroidism amplifies catecholamine-stimulated lipolysis and increases thermogenesis and oxygen consumption in adipose tissue (1-3). Hypothyroidism reduces the response to catecholamines and increases energy-saving anabolic activity in adipose tissue (4).Thyroid hormone has long been recognized to augment adrenergic activity, and influences adrenergic signaling at multiple levels. Catecholamines bind at least five subtypes of adrenergic receptors (␣1, ␣2, 1, 2, and 3) that are expressed in fat cells and are coupled with the adenylylcyclase system to activate (via  receptors) or inhibit (via ␣2 receptor) the cAMPactivated hormone-sensitive lipase (HSL) 1 (5-9). Reduced catecholamine-stimulated lipolysis in hypothyroidism is thought to be due to a reduced number of -adrenergic receptors (1 and 2) in fat cells (4, 10 -13), reduced interaction with G s , and enhanced G i protein interaction via ␣2-adrenergic receptorcoupled stimulation (14). Additionally, hypothyroidism is associated with low intracellular levels of protein kinase, known to phosphorylate and activate HSL (2,12,13). No significant alteration of ␣2-adrenergic receptor number has been found in fat cells isolated from either hypo-or hyperthyroid animals (6).The two majo...